The pandemic COVID-19 needs a rapid microbiological diagnostic from Clinical Microbiology Units. Due to the fact that it is done by using a reverse transcription polymerase chain reaction (rRT-PCR) previous RNA extraction and automated equipment and reagents for RNA extraction represent an economic increase to the diagnosis, we describe an easy, cost-effective and fast alternative extraction-free SARS-CoV-2. Samples were treated with proteinase K for 10 minutes at 55°C. Then, there is a heat-process for 5 minutes at 98°C and finally, 3 minutes at -20°C before a commercial-commonly-used rRT-PCR procedure. The RNA automated-extraction was also performed with QIAsymphony RNA Kit (Qiagen) equipment. A total of 220 nasopharyngeal and oropharyngeal swabs were analyzed. 113 samples were tested positive whereas 106 samples were tested negative with RNA automated-extraction and extraction-free method, for an agreement of 99%. A total of one discordant sample was noted in which no amplified result (gene ORF1ab and N) were observed by RNA automated-extraction and gene ORF1ab (Ct 39) and gene N (Ct 37) by extraction-free. Thus, results were comparable with automated-extraction. This method is not only clinically acceptable but also confers an easy, fast, and cost-effective alternative to automated-extraction. Therefore, microbiological laboratories, with low economics resources and/or without automated-extraction equipment, could incorporate it.
Published in | International Journal of Biomedical Engineering and Clinical Science (Volume 7, Issue 2) |
DOI | 10.11648/j.ijbecs.20210702.13 |
Page(s) | 30-34 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
SARS-CoV-2, COVID-19, Molecular Diagnosis, Cost-effective
[1] | WHO. Coronavirus disease (COVID-19) pandemic [Internet]. www.who.int: WHO; 2020 [updated 2020 20 April]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. |
[2] | Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020, 579 (7798): 270-3. doi: 10.1038/s41586-020-2012-7. |
[3] | Wong JE, Leo YS, Tan CC. COVID-19 in Singapore. Current Experience: Critical Global Issues That Require Attention and Action. JAMA. 2020, 323 (13): 1243-4. doi: 10.1001/jama.2020.2467. |
[4] | Akst J. RNA Extraction Kits for COVID-19 Tests Are in Short Supply in US [Internet]. www.thescientist.com: The Scientist.; 2020 [updated 2020 11 March]. Available from: https://www.the-scientist.com/news-opinion/rna-extraction-kits-for-covid-19-tests-are-in-shortsupply-in-us-67250. |
[5] | Chu DKW, Pan Y, Cheng SMS, Hui KPY, Krishnan P, Liu Y, et al. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia. Clin Chem.2020. 66 (4): 549-55. doi: 10.1093/clinchem/hvaa029. |
[6] | Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020, 25 (3). doi: 10.2807/1560-7917.ES.2020.25.3.2000045. |
[7] | Kim D, Lee JY, Yang JS, Kim JW, Kim VN, Chang H. The architecture of SARS-CoV-2 transcriptome. Cell. 2020, 181 (4): 914–2110. |
[8] | Bullard J, Dust K, Funk D, Strong JE, Alexander D, Garnett L, et al. Predicting infectious SARS-CoV-2 from diagnostic samples. Clin Infect Dis. 2020. https://doi.org/10.1093/cid/ciaa638. |
[9] | La Scola B, Le Bideau M, Andreani J, Hoang VT, Grimaldier C, Colson P, et al. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur J Clin Microbiol Infect Dis. 2020, 39 (6): 1059–61. |
[10] | Zheng S, Fan J, Yu F, Feng B, Lou B, Zou Q, et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January–March 2020: retrospective cohort study. BMJ. 2020, 369: m1443. |
[11] | Huang CG, Lee KM, Hsiao MJ, Yang SL, Huang PN, Gong YN, et al. Culturebased virus isolation to evaluate potential infectivity of clinical specimens tested for COVID-19. J Clin Microbiol. 2020. https://doi.org/10.1128/ JCM.01068-20. |
[12] | Folgueira MD, Luczkowiak J, Lasala F, Perez-Rivilla A, Delgado R. Persistent SARS-CoV-2 replication in severe COVID-19. medRxiv. 2020. https://doi. org/10.1101/2020.06.10.20127837. |
[13] | Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020, 382 (12): 1177–9. |
[14] | Fomsgaard AS and Rosenstierne MW. An alternative workflow for molecular detection of SARS-CoV-2 - escape from the NA extraction kit-shortage, Copenhagen, Denmark. March, 2020. https://doi.org/10.1101/2020.03.27.20044495. |
[15] | Mallmann L, Schallenberger K, Demolliner M, Antunes Eisen AK, Saraiva Hermann B, Heldt FH, et al. Pre-treatment of the clinical sample with Proteinase K allows detection of SARS-CoV-2 in the absence of RNA extraction. 2020. https://doi.org/10.1101/2020.05.07.083139. |
APA Style
Carme Salvador-Garcia, Maria Dolores Ocete-Mochon, Rafael Medina-Gonzalez, Begona Fuster-Escriva, Sonia Cortes-Badenes, et al. (2021). SARS-CoV-2 Detection: Fast and Cost-Effective Sample Processing Prior to RT-PCR. International Journal of Biomedical Engineering and Clinical Science, 7(2), 30-34. https://doi.org/10.11648/j.ijbecs.20210702.13
ACS Style
Carme Salvador-Garcia; Maria Dolores Ocete-Mochon; Rafael Medina-Gonzalez; Begona Fuster-Escriva; Sonia Cortes-Badenes, et al. SARS-CoV-2 Detection: Fast and Cost-Effective Sample Processing Prior to RT-PCR. Int. J. Biomed. Eng. Clin. Sci. 2021, 7(2), 30-34. doi: 10.11648/j.ijbecs.20210702.13
AMA Style
Carme Salvador-Garcia, Maria Dolores Ocete-Mochon, Rafael Medina-Gonzalez, Begona Fuster-Escriva, Sonia Cortes-Badenes, et al. SARS-CoV-2 Detection: Fast and Cost-Effective Sample Processing Prior to RT-PCR. Int J Biomed Eng Clin Sci. 2021;7(2):30-34. doi: 10.11648/j.ijbecs.20210702.13
@article{10.11648/j.ijbecs.20210702.13, author = {Carme Salvador-Garcia and Maria Dolores Ocete-Mochon and Rafael Medina-Gonzalez and Begona Fuster-Escriva and Sonia Cortes-Badenes and Maria Carmen Breso-Vila and Maria Jose Lahiguera-Abalos and Concepcion Gimeno-Cardona}, title = {SARS-CoV-2 Detection: Fast and Cost-Effective Sample Processing Prior to RT-PCR}, journal = {International Journal of Biomedical Engineering and Clinical Science}, volume = {7}, number = {2}, pages = {30-34}, doi = {10.11648/j.ijbecs.20210702.13}, url = {https://doi.org/10.11648/j.ijbecs.20210702.13}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijbecs.20210702.13}, abstract = {The pandemic COVID-19 needs a rapid microbiological diagnostic from Clinical Microbiology Units. Due to the fact that it is done by using a reverse transcription polymerase chain reaction (rRT-PCR) previous RNA extraction and automated equipment and reagents for RNA extraction represent an economic increase to the diagnosis, we describe an easy, cost-effective and fast alternative extraction-free SARS-CoV-2. Samples were treated with proteinase K for 10 minutes at 55°C. Then, there is a heat-process for 5 minutes at 98°C and finally, 3 minutes at -20°C before a commercial-commonly-used rRT-PCR procedure. The RNA automated-extraction was also performed with QIAsymphony RNA Kit (Qiagen) equipment. A total of 220 nasopharyngeal and oropharyngeal swabs were analyzed. 113 samples were tested positive whereas 106 samples were tested negative with RNA automated-extraction and extraction-free method, for an agreement of 99%. A total of one discordant sample was noted in which no amplified result (gene ORF1ab and N) were observed by RNA automated-extraction and gene ORF1ab (Ct 39) and gene N (Ct 37) by extraction-free. Thus, results were comparable with automated-extraction. This method is not only clinically acceptable but also confers an easy, fast, and cost-effective alternative to automated-extraction. Therefore, microbiological laboratories, with low economics resources and/or without automated-extraction equipment, could incorporate it.}, year = {2021} }
TY - JOUR T1 - SARS-CoV-2 Detection: Fast and Cost-Effective Sample Processing Prior to RT-PCR AU - Carme Salvador-Garcia AU - Maria Dolores Ocete-Mochon AU - Rafael Medina-Gonzalez AU - Begona Fuster-Escriva AU - Sonia Cortes-Badenes AU - Maria Carmen Breso-Vila AU - Maria Jose Lahiguera-Abalos AU - Concepcion Gimeno-Cardona Y1 - 2021/06/04 PY - 2021 N1 - https://doi.org/10.11648/j.ijbecs.20210702.13 DO - 10.11648/j.ijbecs.20210702.13 T2 - International Journal of Biomedical Engineering and Clinical Science JF - International Journal of Biomedical Engineering and Clinical Science JO - International Journal of Biomedical Engineering and Clinical Science SP - 30 EP - 34 PB - Science Publishing Group SN - 2472-1301 UR - https://doi.org/10.11648/j.ijbecs.20210702.13 AB - The pandemic COVID-19 needs a rapid microbiological diagnostic from Clinical Microbiology Units. Due to the fact that it is done by using a reverse transcription polymerase chain reaction (rRT-PCR) previous RNA extraction and automated equipment and reagents for RNA extraction represent an economic increase to the diagnosis, we describe an easy, cost-effective and fast alternative extraction-free SARS-CoV-2. Samples were treated with proteinase K for 10 minutes at 55°C. Then, there is a heat-process for 5 minutes at 98°C and finally, 3 minutes at -20°C before a commercial-commonly-used rRT-PCR procedure. The RNA automated-extraction was also performed with QIAsymphony RNA Kit (Qiagen) equipment. A total of 220 nasopharyngeal and oropharyngeal swabs were analyzed. 113 samples were tested positive whereas 106 samples were tested negative with RNA automated-extraction and extraction-free method, for an agreement of 99%. A total of one discordant sample was noted in which no amplified result (gene ORF1ab and N) were observed by RNA automated-extraction and gene ORF1ab (Ct 39) and gene N (Ct 37) by extraction-free. Thus, results were comparable with automated-extraction. This method is not only clinically acceptable but also confers an easy, fast, and cost-effective alternative to automated-extraction. Therefore, microbiological laboratories, with low economics resources and/or without automated-extraction equipment, could incorporate it. VL - 7 IS - 2 ER -